J
Juan C. Alejos
Researcher at University of California, Los Angeles
Publications - 80
Citations - 2061
Juan C. Alejos is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Transplantation & Heart transplantation. The author has an hindex of 25, co-authored 70 publications receiving 1881 citations. Previous affiliations of Juan C. Alejos include University of Southern California & Children's Hospital Los Angeles.
Papers
More filters
Journal ArticleDOI
Lower spatial QRS-T angle rules out sustained ventricular arrhythmias in children with hypertrophic cardiomyopathy.
Daniel Cortez,Nandita Sharma,Jean Cavanaugh,Froilan Tuozo,Gwendolyn Derk,Emily Lundberg,Keith Weiner,Nafiz Kiciman,Juan C. Alejos,Bruce F. Landeck,Jamil Aboulhosn,Shelley D. Miyamoto,Anthony C. McCanta,Anjan S. Batra +13 more
TL;DR: In children with hypertrophic cardiomyopathy, the spatial peaks QRS-T angle is associated with ventricular arrhythmia burden with high negative predictive value and odds ratio.
Journal ArticleDOI
Minimally invasive mechanical cardiac support without extracorporeal membrane oxygenation in children awaiting heart transplantation
TL;DR: Pediatric patients with dilated cardiomyopathy may benefit from a left ventricular assist technique using a centrifugal pump, which avoids the neck vessels and sternotomy, as well as ECMO.
Journal ArticleDOI
An Approach to the Treatment of Pediatric Myocarditis
Daniel S. Levi,Juan C. Alejos +1 more
TL;DR: The newest treatment strategies for pediatric myocarditis have evolved from an understanding of the pathophysiology of myocyte damage, and supportive therapy continues to remain the cornerstone of treatment.
Journal ArticleDOI
Right sided heart failure and pulmonary hypertension: New insights into disease mechanisms and treatment modalities ☆
TL;DR: New research on the mechanisms of PH induced right heart failure are highlighted, as well as the latest PH treatments aimed at improving or sustaining right heart function are reviewed.
Journal ArticleDOI
Outcomes of fetal listed patients awaiting heart transplantation.
Jennifer Conway,Maryanne R.K. Chrisant,Lori J. West,Rebecca K. Ameduri,Juan C. Alejos,Jacqueline M. Lamour,Bibhuti B. Das,D.J. Gilbert,Margaret Tresler,David C. Naftel,Shelley D. Miyamoto +10 more
TL;DR: By six months post‐listing, a higher proportion of fetal listed patients had undergone HTx with a lower waitlist mortality when compared with neonate, indicating that fetal listing can be a reasonable option.